The Man | The Investor| Jacob Gottlieb

Jacob Gottlieb is an accomplished financial entrepreneur who is known as the titan of healthcare investing. While studying at Brown University, he received his BA in Economics and then went on to earn an MD from New York University Medical School. In 2001, Gottlieb earned his CFA (Chartered Financial Analyst) from the AIMR (Association for Investment Management and Research); and then in 2010, he received his P.R.M from the Professional Risk Managers’ International Association. Given Gottlieb extensive academic background, he used his passion for medicine to invest in the financial industry. Furthermore, Gottlieb has also connected with Stuart Weisbrod. They are both big sharks in the healthcare industry and are working together for future collaborations.

Recently, Gottlieb has started a new endeavor called Altium Capital. Based in New York City, Altium gears its investments toward the healthcare industry. Their investments are focused on company growth in the healthcare industry; advances explicitly in health and medicine.

Altium has invested in Amarin Corporation (AMRN), Oragenics, and Oramed Pharmaceuticals (ORMP). Oramed is an innovative oral alternative treatment for diabetic patients. ORMP has tested their treatment and released their ingestible insulin capsule to the masses. Furthermore, Altium invested 5.61% stake in this company.

Before Altium, Visium Asset Management was founded by Gottlieb in 2005. Visium was very successful for about a decade. It had grossed over $8 billion and had global offices with over 200 employees. These offices were in New York City, San Francisco, and London. Unfortunately, in 2016 there was a trading scandal that forced Visium to let go of its entire team.

Also, prior to Visium, Gottlieb was the founding member at Balyasny Asset Management. At BAM, he was known as a top earner because of its extensive portfolio. Before Visium, Gottlieb worked for the Merlin in New York City as an investment portfolio manager. Also, for two years Gottlieb was a buy-side analyst at Sanford C. Bernstein & Co., LLC and covered global health care.